Skip to content

Patient derived cancer xenograph genome analysis

Notifications You must be signed in to change notification settings

evan-wehi/pdx-genome-ok

 
 

Folders and files

NameName
Last commit message
Last commit date

Latest commit

 

History

54 Commits
 
 
 
 
 
 
 
 
 
 
 
 

Repository files navigation

pdx-genome

Patient derived cancer xenograph genome analysis

  1. Trimmomatic palindrome mode with high threshold (20)
  2. Mapping paired end local alignment with either bwa-mem or bowtie2 to GRCh38_no_alt and GRCm38 preserving read order and only reporting one alignment per read.
  3. Processing the mouse and human alignments with xenomapper (needs only python3 and a samtools binary in the path. Pip3 installable)
  4. Samtools sort and index human reads

Using the human specific reads for:

  1. Platypus mutation calling (tumour only)
  2. Varscan mutation calling (tumour only)
  3. Gridss
  4. Annotation of variants with VEP including population variant frequencies (ExAC)

Instructions

  1. Create a new empty directory to hold code, scripts and output
  2. Clone this repository: git clone --recursive https://github.com/WEHI-ResearchComputing/pdx-genome Note the recursive argument to bring in the common tool definitions.
  3. Create a python virtual enviroment to hold the software
    • module load python
    • virtualenv toil-env
    • . toil-env/bin/activate
    • pip install git+https://github.com/WEHI-ResearchComputing/wehi-pipeline
  4. You should now be able to run the tests against the minimal data in the pdx-genome/data directory.
    1. Test with the CWL reference implementation
      • cd /path/to/pdx-genome
      • mkdir test
      • cd test
      • cwltool ../src/pdx-scatter.cwl ../src/pdx-inp.yml
    2. Test with Toil. Inspect the runall.sh script and make sure the directories are correct.

About

Patient derived cancer xenograph genome analysis

Resources

Stars

Watchers

Forks

Releases

No releases published

Packages

 
 
 

Languages

  • Common Workflow Language 97.5%
  • Shell 2.5%